Wednesday, November 22, 2017 10:45:56 AM
ISODIOL INTERNATIONAL INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE BRADLEY'S BIOSCIENCE INC., AND CLOSES STRATEGIC FINANCING
Isodiol International Inc. has entered into a definitive agreement in connection with its previously announced letter of intent to acquire Bradley's Bioscience Inc., a leading manufacturer and distributer of hemp oil and nicotine e-liquids.
"The acquisition of Bradley's Bioscience, a market poised to be a $61.4-billion industry by 2025 is another major milestone for the company," said Marcos Agramont, chief executive officer of Isodiol. "Not only does this allow the company to penetrate a new market, but we are now also able to provide consumers with a safer alternative to smoking. Over all, we believe Bradley's Bioscience is a perfect fit with Isodiol and our long-term vision and we are very pleased to be moving forward with this agreement."
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM